---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-005516"
form_type: "8-K"
ticker: "AGL"
cik: "0001831097"
company_name: "agilon health, inc."
filed_at: "2023-03-01T23:59:59+00:00"
generated_at: "2026-06-18T18:46:05.885220+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# agilon health Q4 revenue up 49% to $690M; FY2022 Adjusted EBITDA turns positive; guides 2023 EBITDA $75-90M

## Summary
- Q4 revenue $690M (+49% YoY); FY2022 revenue $2.71B (+48%). Medicare Advantage members 269,500 (+45%).
- Q4 medical margin $61M (+93%); FY2022 medical margin $305M (+67%). Medical margin rate 8.8% Q4, 11.2% FY.
- Q4 net loss $57M (flat YoY); FY2022 net loss $107M vs $407M (includes $292M non-cash stock comp in 2021).
- FY2022 Adjusted EBITDA positive $4M vs negative $39M; Q4 Adjusted EBITDA negative $11M vs negative $27M.
- Completed acquisition of mphrX on Feb 28, 2023; expects 2023 revenue $4.28-4.37B, Adjusted EBITDA $75-90M.

## SEC filing metadata
- accession: 0000950170-23-005516
- form_type: 8-K
- ticker: AGL
- cik: 0001831097
- company_name: agilon health, inc.
- filed_at: 2023-03-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831097/000095017023005516/0000950170-23-005516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831097/000095017023005516/agl-20230301.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-005516
- JSON: https://secwatch.observer/filing/0000950170-23-005516.json
- Plain text: https://secwatch.observer/filing/0000950170-23-005516.txt

## Key facts
- Earnings Releases
  agilon health, inc. reported the quarter ended December 31, 2022 results: revenue $690 million, net income Net loss of $57 million. Guidance initiated.
  - Period: the quarter ended December 31, 2022
  - Revenue: $690 million
  - Net income: Net loss of $57 million
  - Guidance: initiated
  - Result: reported results
  source text: Total revenue of $690 million increased 49% during the fourth quarter compared to $463 million in the fourth quarter 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000095017023005516/0000950170-23-005516-index.htm
- Earnings Releases
  agilon health, inc. reported the fiscal year ended December 31, 2022 results: revenue $2.71 billion, net income Net loss of $107 million. Guidance initiated.
  - Period: the fiscal year ended December 31, 2022
  - Revenue: $2.71 billion
  - Net income: Net loss of $107 million
  - Guidance: initiated
  - Result: reported results
  source text: For the fiscal year 2022, total revenue of $2.71 billion increased 48% compared to $1.83 billion in the comparable 2021 period.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1831097/000095017023005516/0000950170-23-005516-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.